In a randomized , double blind , and placebo-controlled trial , 90 young individuals , aged 10 to 18 years , with metabolic syndrome were randomly assigned to receive either vitamin E tablets ( 400IU/day ) or omega-3 tablets ( 2.4 gr/day ) or placebo .